Summary
The clinical, biochemical, and hematologic findings in 16 patients with Laennec's cirrhosis and predominantly indirect hyperbilirubinemia are presented. Three patients had previously undergone a portacaval shunt. The mean51Cr-labeled red-cell halflife obtained in 12 of the cirrhotics with indirect hyperbilirubinemia was 17.9 days, compared to a mean of 23.6 days in the control group of 12 cirrhotics with direct hyperbilirubinemia. This difference was statistically significant (p<0.01).
There was a tendency for the serum indirect bilirubin concentration and the red-cell halflives to be inversely related in the patients with indirect hyperbilirubinemia.
Splenic sequestration of red cells was demonstrated in 5 of 10 patients with indirect hyperbilirubinemia and in 1 patient from the control group.
Similar content being viewed by others
References
van den Bergh, A. A. H., andMüller, P. Uber eine direkte und eine inderkte Diazoreaktion auf Bilirubin.Biochem Z 77:90, 1916.
Billing, B. H., Cole, P. G., andLathe, G. H. Excretion of bilirubin as diglucuronide giving direct, van den Bergh reaction.Biochem J 65:774, 1957.
Schmid, R. Identification of “direct reacting” bilirubin as bilirubin glucuronide.J Biol Chem 229:881, 1957.
Levine, R. A., andKlatskin, G. Unconjugated hyperbilirubinemia in the absence of overt hemolysis. Importance of acquired disease as an etiologic factor in 366 adolescent and adult subjects.Amer J Med 36:541, 1964.
Israels, L. G., Suderman, H. J., andRitzman, S. E. Hyperbilirubinemia due to an alternate path of bilirubin production.Amer J Med 27:693, 1959.
Watson, C. J. The importance of the fractional serum bilirubin determination in clinical medicine.Ann Int Med 45:351, 1956.
Hyman, G. A., andSouthworth, H. Hemolytic anemia associated with liver disease.Amer J Med Sci 221:448, 1951.
Chaplin, H., andMollison, P. L. Red cell life-span in nephritis and in hepatic cirrhosis.Clin Sci 12:351, 1953.
Jones, P. N., Weinstein, I. M., Ettinger, R. H., andCapps, R. B. Decreased red cell survival associated with liver disease; use of radioactive sodium chromate in measurement of red cell survival.Arch Intern Med (Chicago) 95:93, 1955.
Jandl, J. H. The anemia of liver disease. Observations on its mechanism.J Clin Invest 34:390, 1955.
Allen, F. A., Carr, M. H., andKlotz, A. P. Decreased red blood cell survival time in patients with portal cirrhosis; correlation of laboratory and clinical findings.JAMA 164:955, 1957.
Sheehy, T. W., andBerman, A. Anemia of cirrhosis.J Lab Clin Med 56:72, 1960.
Cawein, M. J., III, Hagedorn, A. B., andOwen, C. A., Jr. Anemia of hepatic disease studied with radiochromium.Gastroenterology 38:324, 1960.
Conrad, M. E., Jr., Berman, A., andCrosby, W. H. Iron kinetics in Laennec's cirrhosis.Gastroenterology 43:385, 1962.
Katz, R., Velasco, M., Guzman, C., andAlessandri, H. Red cell survival estimated by radioactive chromium in hepatobiliary disease.Gastroenterology 46:399, 1964.
Fauvert, R., Loverdo, A., Nicollo, S., andBoivin, P. L'hémolyse dans les cirrhoses. Étude de 40 cas par le methods des hématies marquées au chrome 51.Path Biol (Paris) 34:1801, 1958.
de Silva, L. C., Jamra, M., Maspes, V., Pontes, J., Pieroni, R., andCintra, A. Pathogenesis of indirect reacting hyperbilirubinemia after portacaval anastomosis.Gastroenterology 44:117, 1963.
Dacle, J. V. Practical Hematology. Churchill, London, 1950.
Henry, R. J., Sobel, C., andChiamori, N. On the determination of serum iron and iron binding capacity.Clin Chim Acta 3:523, 1958.
Henry, R. J., Jacobs, S. C., andBerkman, S. Studies on the determination of bile pigments. III. Standardization of the determination of urobilinogen as urobilinogenaldehyde.Clin Chem 7:231, 1961.
Harrison, G. A. Chemical Methods in Clinical Medicine. Churchill, London, 1937.
Ducci, H., andWatson, C. J. The quantitative determination of the serum bilirubin with special reference to the prompt reacting and the chloroform-soluble types.J Lab Clin Med 30:293, 1945.
Beierwaltes, W. H., Johnson, P. C., andSolari, A. J. Clinical Use of Radioisotopes. Saunders, Philadelphia, 1957.
Lester, R., andSchmid, R. Bilirubin metabolism.New Eng J Med 270:779, 1964.
Robinson, S. H., Owen, C. A., Flock, E. V., andSchmid, R. Bilirubin formation in the liver from nonhemoglobin sources. Experiments with isolated perfused rat liver.Blood 26:823, 1965.
Crosby, W. H. The capacity of bilirubin production as reflected by the concentration of plasma bilirubin.J Clin Invest 37:887, 1958.
Weech, A., Vann, D., andGrillo, R. The clearance of bilirubin from the plasma; a measure of the excreting power of the liver.J Clin Invest 20:323, 1941.
Tisdale, W. A., Klatskin, G., andKinsella, E. D. The significance of the direct-reacting fraction of serum bilirubin in hemolytic jaundice.Amer J Med 26:214, 1959.
Sherlock, S. Diseases of the Liver (ed. 3). Davis, Philadelphia, 1963, p. 242.
Donohue, D. M., Motulsky, A. G., Giblett, E. R., Pirzio-Biroli, G., Viranuvatti, V., andFinch, C. A. The use of chromium as a red cell tag.Brit J Haemat 1:249, 1955.
Bothwell, T. H., andFinch, C. A. Iron Metabolism. Little, Boston, 1962.
Zieve, L. Hemolytic anemia in liver disease.Medicine 45:497–505, 1966.
Author information
Authors and Affiliations
Additional information
Supported by Grant HE 09316 from the National Institutes of Health, United States Public Health Service.
The authors wish to thank Mr. Richard Suzuki for his assistance in performing the red cell survival studies.
Rights and permissions
About this article
Cite this article
Felsher, B.F., Redeker, A.G. & Reynolds, T.B. Indirect reacting hyperbilirubinemia in cirrhosis: Its relation to red cell survival. Digest Dis Sci 13, 598–607 (1968). https://doi.org/10.1007/BF02232966
Issue Date:
DOI: https://doi.org/10.1007/BF02232966